With Clue, women can do just that with a few taps on their smartphone. Today the company is highly competitive in the area of period and fertility tracking. Many other women-specific tools have hit the market. Elvie, a London-based company, has launched a portable breast pump and pelvic exercise trainer and app that both use smart technology. Another part of Femtech, known as "Menotech", aims to improve the lifestyle of women going through menopause and provide access to telemedicine and information and data that women can access.
Finally, there are medical technology companies that focus on cancer that affects women, such as: B. Cervical cancer and breast cancer.
According to the World Health Organization, cervical cancer is the fourth leading cause of cancer in women around the world. In 2018 there were about 570,000 women and 311,000 died. The WHO. in November announced a program to completely eradicate the disease by 2030.
MobileODT, a Tel Aviv-based start-up, uses smartphones and artificial intelligence to check for cervical cancer. A smart colposcope – a portable imaging device one and a half times the size of a smartphone – is used to photograph a woman's cervix from about a meter away. The image is then transmitted to the cloud via a smartphone, where artificial intelligence is used to identify normal or abnormal cervical findings.
A diagnosis is provided in about 60 seconds – compared to the weeks it takes to get the results of a standard smear (which extends to months in developing countries). In addition to this screening, doctors still use smear tests.
The technology was recently used to screen 9,000 women over a three-month period in the Dominican Republic as part of a government-led campaign, the company announced last month. Another 50,000 women are expected to be screened over the next six months.
Leon Boston, the South African-born chief executive of MobileODT, said the privately held company is selling in about 20 different countries, including the US, India, South Korea and Brazil, and is going on a fundraising round to build on seed capital of US $ 24 million Dollar.